Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
976 GBX | +0.10% | +2.52% | -42.01% |
Apr. 24 | Jefferies Cuts CVS Group PT, Maintains at Hold | MT |
Apr. 24 | Investec cuts Hipgnosis Songs Fund to 'hold' | AN |
Sales 2024 * | 671M 838M | Sales 2025 * | 717M 896M | Capitalization | 700M 874M |
---|---|---|---|---|---|
Net income 2024 * | 42M 52.47M | Net income 2025 * | 53M 66.21M | EV / Sales 2024 * | 1.38 x |
Net Debt 2024 * | 222M 278M | Net Debt 2025 * | 179M 224M | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
17.3
x | P/E ratio 2025 * |
13.3
x | Employees | 9,100 |
Yield 2024 * |
0.81% | Yield 2025 * |
0.88% | Free-Float | 98.46% |
Latest transcript on CVS Group plc
1 day | +0.10% | ||
1 week | +2.52% | ||
Current month | +0.10% | ||
1 month | -0.81% | ||
3 months | -42.52% | ||
6 months | -29.78% | ||
Current year | -42.01% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Fairman
CEO | Chief Executive Officer | 57 | 18-07-31 |
Robin Alfonso
DFI | Director of Finance/CFO | 45 | 19-11-05 |
Richard Killen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Deborah Kemp
CHM | Chairman | 62 | 18-01-01 |
David Wilton
BRD | Director/Board Member | 61 | 21-09-23 |
Richard Fairman
CEO | Chief Executive Officer | 57 | 18-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.84% | 1 M€ | -.--% | ||
0.04% | 773 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 976 | +0.10% | 215,662 |
24-04-25 | 975 | +1.46% | 162,234 |
24-04-24 | 961 | +1.16% | 914,266 |
24-04-23 | 950 | +0.11% | 582,890 |
24-04-22 | 949 | -0.32% | 398,044 |
Delayed Quote London S.E., April 26, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.01% | 872M | |
-33.57% | 130M |
- Stock Market
- Equities
- CVSG Stock